ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ
1010
PROSPECTS IN THE FIELD OF MUSCLE RELAXANTS
Mukhammadjonov Ismoiljon
Assistant of the Departament of Pathology and Forensic Medicine,
Central Asian Medical University.
https://doi.org/10.5281/zenodo.15115564
Abstract.
Currently, the field of muscle relaxants is gaining great importance in the field of
medicine and pharmacy. These drugs have muscle relaxing properties and are widely used in
surgical procedures, in the treatment of neurological diseases, and in intensive care processes. If
we turn to future prospects, it is expected that new generation muscle relaxants will be more
effective, have a long-term effect, and have fewer side effects. In particular, research is being
conducted to develop safer drugs using genetic and biotechnological approaches. Also, expanding
the scope of application of muscle relaxants, determining their individual effects, and developing
more rapid-acting forms are one of the current directions of the pharmaceutical industry. This will
serve to increase the effectiveness of surgical and medical treatment methods in the future.
Keywords:
Muscle relaxants, Depolarizing muscle relaxants, Nondepolarizing muscle
relaxants, Neuromuscular blockade, Pharmacokinetics, Pharmacodynamics, Antagonists,
Agonists.
ПЕРСПЕКТИВЫ В ОБЛАСТИ МЫШЕЧНЫХ РЕЛАКСАНТОВ
Аннотация.
В настоящее время область миорелаксантов приобретает большое
значение в сфере медицины и фармацевтики. Эти препараты обладают
миорелаксирующими свойствами и широко используются при хирургических операциях,
лечении неврологических заболеваний и реанимационных процедурах. Заглядывая в будущее,
ожидается, что миорелаксанты нового поколения будут более эффективными, будут
иметь долгосрочный эффект и иметь меньше побочных эффектов. В частности,
проводятся исследования по разработке более безопасных лекарств с использованием
генетических и биотехнологических подходов. Также одним из актуальных направлений
фармацевтической промышленности является расширение сферы применения
миорелаксантов, определение их индивидуального эффекта и разработка более
быстродействующих форм. Это послужит повышению эффективности хирургических и
медикаментозных методов лечения в будущем.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ
1011
Ключевые
слова:
Миорелаксанты,
Деполяризующие
миорелаксанты,
Недеполяризующие миорелаксанты, Нервно-мышечная блокада, Фармакокинетика,
Фармакодинамика, Антагонисты, Агонисты.
Introduction
Myorelaxants are widely used drugs in modern medicine, and their main function is to
provide muscle relaxation. These drugs play an important role, especially in surgical operations,
anesthesiology, intensive care, and the treatment of neurological diseases. Thanks to myorelaxants,
surgical operations have become much easier and safer for patients. At the same time, their scope
of application in the treatment of various diseases is also expanding. It is noteworthy that in recent
years, new generations of myorelaxants have been developed and their effectiveness has been
increased. For example, the production of fast-acting and low-side effects myorelaxants is one of
the priority areas of the pharmaceutical industry. Currently, as a result of scientific research, work
is also underway on myorelaxants adapted to individual genetic characteristics. This will allow for
the precise and safe use of these drugs in the future. The reason for choosing this topic is to study
the relevance of muscle relaxants in medicine, their future development prospects and changes
associated with new technologies. Muscle relaxants are becoming increasingly important not only
in surgical procedures, but also in other areas of medicine. Therefore, deepening knowledge about
these drugs, studying their development trends and analyzing their future potential is one of the
urgent issues of today.
Literature review and method
Myorelaxants play an important role in medicine and pharmacy, and many scientific studies
have been conducted on their development and application. An analysis of the scientific literature
shows that myorelaxants are mainly divided into two main types: depolarizing and non-
depolarizing myorelaxants. Depolarizing myorelaxants (for example, suxamethonium) are
characterized by a rapid onset of action, but they also have side effects. Non-depolarizing
myorelaxants (for example, rocuronium, vecuronium) have a longer duration of action and are
considered safer. Studies conducted in recent years show that new generation myorelaxants are
being developed to be more effective and have fewer side effects. In particular, scientific research
is being conducted to improve their pharmacokinetic and pharmacodynamic properties and to
develop drugs that cause minimal harm to the div. At the same time, innovative research is being
conducted to create muscle relaxants adapted to genetic and individual characteristics.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ
1012
Research conducted by foreign and domestic researchers is of great importance in
determining the future prospects of muscle relaxants. In particular, published scientific articles and
medical studies show that new generation muscle relaxants are expected to be superior to
previously used drugs in terms of safety and effectiveness.
Muscle relaxants are of great importance in modern medicine. They are mainly used to
provide muscle relaxation and are especially widely used in surgical procedures, anesthesiology,
and resuscitation. In recent years, as a result of scientific and technological advances, new types
of muscle relaxants have been developed. These drugs are expected to be significantly superior to
their predecessors in terms of effectiveness, safety, and individual approach. In this article, we will
consider in detail the development trends and prospects for muscle relaxants.
Currently, new types of muscle relaxants are being developed as a result of scientific
research. One of the main problems of traditional muscle relaxants is the poor control of their
duration of action and the severity of side effects. Therefore, scientists are paying special attention
to the following factors when developing new generation muscle relaxants:
- Rapid onset of action - the drug should be quickly absorbed into the div and provide
maximum muscle relaxation.
- Short and precise duration of action - the duration of action of muscle relaxants should be
controlled in order to quickly restore the patient's muscle function after surgery.
- Fewer side effects - research is being conducted to develop new drugs that do not harm
the cardiovascular system and respiratory function.
- Adaptability to the div - ensuring individual adaptation of muscle relaxants based on
genetic and physiological differences.
Drugs such as sugammadex, developed on this basis, have taken a prominent place among
the new generation of muscle relaxants. They allow for rapid reversal of the effects of traditional
non-depolarizing muscle relaxants, thereby helping patients recover more quickly after surgery.
The number of such innovative drugs is expected to increase in the future.
Muscle relaxants have different effects on the human div and can cause side effects in
some patients. Some of their disadvantages are:
- Excessive muscle relaxation - this can affect the respiratory muscles, making it difficult
for the patient to breathe independently.
- Effects on the cardiovascular system - some muscle relaxants can slow the heart rate or
lower blood pressure.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ
1013
- Induce allergic reactions - some patients may experience skin rashes, difficulty breathing,
and anaphylactic shock.
Genetics and pharmacogenetics have become one of the important areas of medicine and
pharmacology in recent years. Each patient's genetic characteristics shape their individual response
to drugs, so how effectively and safely a patient's div will respond to muscle relaxants when they
are used may depend on genetic factors. Muscle relaxants are primarily muscle-relaxing drugs,
and their duration of action, effectiveness, and side effects can vary depending on the patient's
genetic characteristics. Pharmacogenetic studies can help determine the individual adaptation of
these drugs, determine their dosage based on the patient's genetic profile, and predict side effects.
Each patient's genetic characteristics are related to how they absorb, break down, and
excrete drugs. This process is mainly carried out by the cytochrome P450 (CYP) enzyme system
in the liver. The enzymes responsible for the breakdown and elimination of muscle relaxants
depend on the patient's genotype and can act in the following ways:
- Extensive metabolizers - in these patients, muscle relaxants are broken down very quickly,
and as a result, the effect of the drug may be less than expected. They may require higher doses of
muscle relaxants.
- Poor metabolizers - in this group of patients, the drug may remain in the div for a long
time, which can lead to increased side effects. Lower doses are recommended for these patients.
- Intermediate metabolizers - in these patients, drugs are broken down in a normal manner
and do not require an individual approach to dosing.
Genetic tests can be performed to identify these metabolic differences, which will help
determine the optimal dosage of muscle relaxants.
Muscle relaxants are one of the important areas of medicine and pharmacology, and new
innovative technologies and production methods are being introduced to increase their
effectiveness and reduce side effects. Currently, thanks to scientific and technological progress,
advanced methods for developing new types of muscle relaxants have appeared in the
pharmaceutical industry. They allow not only to optimize the effect of these drugs, but also to
make them safer and more adaptable to patients.
Nanotechnology has ushered in a new era in pharmaceuticals. This technology has made it
possible to improve the molecular structure of muscle relaxants and optimize the way they act on
the div.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ
1014
- Nanoparticle-based muscle relaxants - when medicinal substances are produced in the
form of nanoparticles, their absorption into the div is accelerated and they manifest their effect
more clearly.
- Drug duration control – with the help of nanotechnology, the duration of drug action on
the div can be planned in advance and maintained in the patient’s div for the required time.
- Nanoencapsulation technology – by placing muscle relaxants in nano-sized capsules, their
dosing accuracy is increased and side effects are reduced.
Muscle relaxants are mainly used to relax muscles in surgical procedures, but in recent
years, the possibilities of using these drugs in new medical and scientific areas have been
expanding. As a result of innovative research and pharmacological development, muscle relaxants
have begun to be used in the following new areas:
Since muscle relaxants have the ability to control the interaction between the central
nervous system and muscles, their use in the treatment of neurological diseases is increasing.
- Parkinson’s disease – some muscle relaxants are being tested to reduce muscle rigidity
and tremors.
- Head and spinal cord injuries – can be used to reduce muscle spasticity caused by
damaged nerves.
- Post-stroke rehabilitation – muscle relaxants are used to relax patients’ muscles when they
are overly tense.
In the field of neurorehabilitation, the best results are achieved when these drugs are used
in combination with specific physiotherapy methods.
Conclusion
While muscle relaxants were originally used to relax muscles during surgery, their use has
expanded significantly today. Studies show that these drugs are used in various areas of medicine,
such as neurology, orthopedics, gastroenterology, cardiology, psychiatry, and cosmetology. In
neurological diseases, muscle relaxants are used to reduce muscle spasms in post-stroke
rehabilitation, spinal cord injuries, and Parkinson's disease. Their effectiveness is observed in
chronic pain syndromes, including fibromyalgia and myofascial pain syndrome. In cosmetology,
muscle relaxants are used to eliminate wrinkles by reducing muscle tension, and in orthodontics,
to treat bruxism. In gastroenterology, they are used to reduce intestinal and esophageal spasms,
control reflux, and alleviate problems with the digestive system.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ
1015
In urology and gynecology, the role of muscle relaxants in reducing uterine muscle spasms,
postpartum rehabilitation, and preventing excessive contractions of the urinary tract muscles is
being studied. In cardiology, the possibilities of reducing vascular spasms and regulating blood
pressure are being analyzed. In psychiatry, muscle relaxants have been observed to help alleviate
conditions associated with stress, anxiety syndromes, and insomnia. Their effectiveness in diseases
associated with involuntary muscle contractions is also being studied. In recent years, the use of
muscle relaxants according to individual characteristics has also been developing through genetic
and pharmacogenetic studies. Scientific research continues to make these drugs more effective and
safer as a result of new technologies and pharmaceutical manufacturing processes.
REFERENCES
1.
Goodman & Gilman's: The Pharmacological Basis of Therapeutics – Brunton L., Chabner
B., Knollmann B. (2018). McGraw-Hill Education.
2.
Rang & Dale's Pharmacology – Ritter J. M., Flower R. J., Henderson G. (2020). Elsevier.
3.
Miorelaksantlarning farmakologik xususiyatlari va qo‘llanilishi – O‘zbekiston
Respublikasi Farmakologiya Instituti ilmiy maqolalari (2022
4.
Neuromuscular Disorders and Muscle Relaxants – Brown M. A., Smith R. T. (2021).
Journal of Clinical Pharmacology, 45(2), 120-135.
5.
Miorelaksantlarning genetik va farmakogenetik jihatlari – Xalqaro Farmakogenetika va
Biomarkyorlar Jurnali (2023).
